Page 235 - Clinical Small Animal Internal Medicine
P. 235

20  Ventricular Arrhythmias  203


  VetBooks.ir


























               Figure 20.6  Six‐lead ECG from a dog with an accelerated idioventricular rhythm. Note that the initial seven beats are wide and bizarre in
               morphology as typical for ventricular ectopy, but the rate is slow (approximately 125 bpm). When the idioventricular rhythm breaks
               spontaneously, normal sinus beats are then seen (arrows) at a rate of approximately 90 bpm. (Paper speed 50 mm/s, sensitivity 5 mm/mV.)


               ventricular tachycardia, the more likely a beat will fall   Table 20.1  Typical medication doses
               within the vulnerable period and induce ventricular
               fibrillation (R‐on‐T phenomenon). Polymorphic ventric-  Drug name  Dosage
               ular tachycardia is also thought to be more dangerous
               than monomorphic ventricular tachycardia. As men-   Amiodarone  Oral: 10–20 mg/kg PO q24h for 7–10 days
               tioned above, certain patient groups appear to have an          then reduce to 3–15 mg/kg PO q24–48 h
               increased risk of sudden death associated with ventricu-        thereafter (D)
               lar tachycardia.                                    Atenolol    Oral: 0.2–1 mg/kg q12–24h (D), 6.25–12.5 mg
                                                                               q12–24h (C)
                                                                   Esmolol     IV bolus: 0.2–0.5 mg/kg over 1 min, repeat
               Acute Therapy of Ventricular Tachycardia                        q5min (D, C)
               Initial therapy for dogs or cats with ventricular tachycar-  Lidocaine  IV bolus: 2 mg/kg over 30 s; maximum three
               dia that is thought to be malignant and directly related to     boluses (D)
                                                                               0.25–0.5 mg/kg (C)
               the current clinical signs is an IV bolus of lidocaine          CRI 25–80 μg/kg/min (D)
               (see Table 20.1 for doses).                         Mexiletine  Oral: 4–8 mg/kg PO q8h (D)
                 Lidocaine should be used with caution in cats, as they
               are very sensitive to its CNS effects. In both cats and   Procainamide  IV bolus: 5–15 mg/kg over 1 min (D)
                                                                               1–2 mg/kg (C)
               dogs, it is important to determine plasma or serum              CRI 20–50 μg/kg/min (D)
               potassium concentration as lidocaine will be less effec-  Sotalol  Oral: 1–3 mg/kg q12h (D, C)
               tive when hypokalemia is present. Thus, if lidocaine fails
               to convert a ventricular rhythm, assessment of a patient’s   C, cat; D, dog; IV, intravenous; CRI, constant rate infusion; PO, by
               electrolyte values, specifically potassium, is required.   mouth (per os).
               Additionally, hyperkalemia can also be a cause of sino-
               ventricular rhythms which can mimic the appearance of   Intravenous procainamide may result in hypotension and
               ventricular tachycardia in a cat.                  should therefore be administered slowly. With refractory
                 Fortunately, most ventricular arrhythmias are respon-  ventricular arrhythmias, magnesium sulfate supplemen-
               sive to therapy with lidocaine. However, some severe   tation can also be considered. Magnesium has primary
               ventricular arrhythmias may not terminate following   antiarrhythmic properties similar to Class III agents, so
               lidocaine injection, and in this situation, IV procaina-  supplementation works well in combination with lido-
               mide would be the next antiarrhythmic to administer.   caine or other Class I agents. Early administration may
   230   231   232   233   234   235   236   237   238   239   240